Acute Allergy Medication
Intramuscular epinephrine is the first-line and only essential medication for acute anaphylaxis—administer immediately at the first sign of systemic allergic reaction, without waiting for symptom progression. 1, 2
First-Line Treatment: Epinephrine
Epinephrine is the drug of choice and must be given promptly at the onset of anaphylaxis symptoms. 3 The evidence is unequivocal across all major guidelines: no other medication should be substituted for or given before epinephrine when anaphylaxis is suspected.
Dosing:
- Adults and children >25-30 kg: 0.3 mg intramuscular (IM) in mid-outer thigh 1, 2
- Children 7.5-25 kg: 0.15 mg IM in mid-outer thigh 1, 2
- Standard concentration: 0.01 mg/kg from 1:1000 solution (maximum 0.5 mg) 3
- Repeat dosing: Can be repeated every 5-15 minutes if symptoms persist or recur 1, 2
Critical principle: When uncertain whether symptoms represent anaphylaxis versus milder allergic reaction, err on the side of administering epinephrine. 1 Physicians cannot predict at symptom onset whether an episode will remain mild or escalate to life-threatening within minutes.
Adjunctive Medications (Never First-Line)
These medications are secondary to epinephrine and should only be given after or alongside epinephrine—never instead of it:
H1-Antihistamines
- Diphenhydramine 25-50 mg (1-2 mg/kg in children) parenterally 3
- Alternative: Cetirizine 10 mg orally (less sedating, relatively rapid onset) 2
- Limitation: Only relieves itching and urticaria; does NOT treat stridor, bronchospasm, hypotension, or shock 2
- Onset too slow: Oral antihistamines take 30-40 minutes for effect, with peak at 60-120 minutes 4
H2-Antihistamines
- Ranitidine 1 mg/kg (12.5-50 mg) IV over 5 minutes, or cimetidine 4 mg/kg IV 3
- Combination of H1 + H2 antihistamines is superior to H1 alone 3
- Evidence is minimal for H2 antihistamines in anaphylaxis 2
Bronchodilators
- Albuterol 2.5-5 mg nebulized in 3 mL saline for bronchospasm resistant to epinephrine 3
- Nebulized therapy preferred over metered-dose inhalers in severe respiratory distress 2
- Does NOT relieve laryngeal edema—cannot substitute for epinephrine 2
Corticosteroids
- NOT helpful acutely due to 4-6 hour onset of action 2
- Given empirically to potentially prevent biphasic/protracted reactions (occurring in up to 20% of cases) 2
- Methylprednisolone 1-2 mg/kg/day IV every 6 hours, or prednisone 0.5 mg/kg orally for less severe episodes 3
- Stop within 2-3 days (all biphasic reactions occur within 3 days) 2
Refractory Anaphylaxis
For patients not responding to IM epinephrine and IV fluids:
- IV epinephrine infusion (1:10,000 solution): 1-3 mg over 3 minutes, then 3-5 mg over 3 minutes, then 4-10 mg/min infusion 3
- Vasopressors (e.g., dopamine 2-20 mcg/kg/min) titrated to blood pressure 3
- Glucagon 1-5 mg IV (20-30 mcg/kg in children, max 1 mg) for patients on beta-blockers who are resistant to epinephrine 3, 2, 3, 2
- Aggressive volume resuscitation with crystalloids or colloids 3
Common Pitfalls to Avoid
Using antihistamines first: The most common reason for not using epinephrine is reliance on antihistamines, which significantly increases risk of progression to life-threatening reaction 5, 4, 6
Waiting for symptom progression: Many patients and caregivers fail to use epinephrine even with severe symptoms like throat tightness, wheezing, or difficulty breathing 1
Fear of epinephrine side effects: Parents worry about hurting their child, but the mortality risk from untreated anaphylaxis far outweighs epinephrine risks 1, 4
Incorrect route: IV epinephrine should only be used in cardiac arrest or profound hypotension unresponsive to IM doses and fluids—requires continuous monitoring 3
Post-Acute Management
- Observation period: 4-6 hours minimum, longer for severe reactions 5
- Prescribe epinephrine auto-injector at discharge 5, 7
- Referral to allergist/immunologist for trigger identification and long-term management 3, 5
The evidence consistently demonstrates that prompt epinephrine administration saves lives, while reliance on antihistamines or other medications as first-line therapy leads to preventable morbidity and mortality. 4, 8